Publications

Search
Found 80 results
Filters: Author is Morgan,S. G.  [Clear All Filters]
Journal Article
Law M., Morgan SG, Majumdar SR, Lynd LD, Marra CA. Effects of prescription adaptation by pharmacists. BMC health services researchBMC Health Serv.Res.. 2010;10:313.
Law M., Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(3):297-302.
Morgan SG, Mintzes B, Barer ML. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Journal of health services research & policyJ.Health Serv.Res.Policy. 2003;8(4):237-244.
Morgan SG. Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004. Healthcare policy = Politiques de santeHealthc.Policy.. 2005;1(1):85-99.
Hanley GE, Morgan SG, Hurley J, van Doorslaer E. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Health economicsHealth Econ.. 2008;17(12):1379-1392.
Morgan SG. Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada. Open medicine : a peer-reviewed, independent, open-access journalOpen Med.. 2007;1(1):e37-45.
Law M., Kawasumi Y, Morgan SG. Despite Law, Fewer Than One In Eight Completed Studies Of Drugs And Biologics Are Reported On Time On Clinical Trials. Health Affairs. 2011;30(12):2338-2345.
Law M., Kawasumi Y, Morgan SG. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Health Affairs. 2011;30(12):2338-2345.
Morgan SG, Kennedy J. Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Morgan SG, Hanley G, Greyson D. Comparing tiered formularies and reference pricing policies: A systematic review. Open Medicine. 2009;3(3).
McMahon M, Morgan SG, Mitton C. The Common Drug Review: a NICE start for Canada? Health policy (Amsterdam, Netherlands)Health Policy. 2006;77(3):339-351.
Hanley G, Morgan SG. Chronic Catastrophes: Exploring the Concentration & Sustained Nature of Ambulatory Rx Drug Expenditures in the Population of BC. Social Science and Medicine. 2009.
Hanley GE, Morgan SG. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social science & medicine (1982)Soc.Sci.Med.. 2009;68(5):919-924.
Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health affairs (Project Hope)Health.Aff.(Millwood). 2006;25(2):337-347.
Morgan SG, McMahon M, Mitton C. Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.
Abelson J, Mendelsohn M, Lavis JN, Morgan SG, Forest PG, Swinton M. Canadians confront health care reform. Health affairs (Project Hope)Health.Aff.(Millwood). 2004;23(3):186-193.
Morgan SG. Canadian prescription drug costs surpass 18 billion dollars. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2005;172(10):1323-1324.
Morgan SG, Bassett KL, Wright JM, Evans RG, Barer ML, Caetano PA, et al. "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada. BMJ (Clinical research ed.)BMJ. 2005;331(7520):815-816.
Morgan SG, Hanley G, Raymond C, Blais R. Breadth, Depth and Agreement among Provincial Formularies in Canada. Healthcare policy = Politiques de santeHealthc.Policy.. 2009;4(4):e162-84.
Morgan SG, Hanley G, Raymond C, Blais R. Breadth, Depth and Agreement Among Provincial Drug Formularies in Canada . Healthcare Policy. 2009;4(4):e162-e184.
Morgan SG. Booming prescription drug expenditure: a population-based analysis of age dynamics. Medical careMed.Care. 2005;43(10):996-1008.
Morgan SG, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health policy (Amsterdam, Netherlands)Health Policy. 2008;87(2):133-145.
Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatric services (Washington, D.C.)Psychiatr.Serv.. 2007;58(1):79-84.
Atlas
Morgan SG, Smolina K, Mooney D, Raymond C, Bowen M, Gorczynski C, et al. Canadian Rx Atlas, 3rd Edition. 3rd ed. Centre for Health Services and Policy Research; 2013.

Pages